EuroQuity Blog
News
Register to the next European Startup Festival in Malmö in September
In 2017 Adriano Travaglia, a lawyer and entrepreneur, and Christine Michaelis, Marketing and Creative Start-Up Coach, saw that there is something missing in the European Startup Ecosystem. An organisation that is working on a European level from the bottom up – not just on an institutional level, including all the relevant stakeholders such as start-ups, investors, public agencies, cities, accelerators, incubators, event organisers etc.
 
They have founded the European Startup Asssociation and now create a borderless, collaborative European Startup Ecosystem. They celebrate the community with their annual European Startup Festival. To capture the different audiences and stakeholders, the festival is moving around countries across Europe – and so is Christine. This way they get to know the start-up ecosystem in each country much quicker and better and build lasting relationships.
 
The first European Startup Festival in Turin was a big success. This year’s 2-day festival is using a similar programme structure but also adding new thing on. They will have interactive panels on topics like innovation, well-being, marketing and communication, team building, sustainability and funding. In addition to that participants can go to as many masterclasses as they like on specialised topics, run by the expert speakers.

The festival is hosted by a British comedian, has a magician and rapper to ensure that it is not only valuable networking and knowledge transfer but also a lot of fun. An evening reception in the old city hall as well as a party and a walking tour through Malmö ensure further networking opportunities for companies, investors, startups and all other participants.
 
Leading up to the European Startup Festival, they also have 6 Pitching Matches across Europe where start-ups meet investors. These are not public events and can only be participated in by applying as a pitching start-up or judge.
 
The main European Startup Festival is happening in Malmö, Sweden, this year on the 20th and 21st September. Easy flights to Copenhagen will get you there in no time!

Tickets are only 140 Euros including all the panels, masterclasses and the evening reception. Join to expand your network on a European level, learn new things, inspiration and have a lot of fun!

You can get your tickets here.
 


Wednesday, June 12th 2019
Register to the next ESIL e-pitch session featuring Medtech startups, on June 25th at 5:00 PM CEST
Our next ESIL pitch session will be held online on June 25th, from 5 to 6 PM CEST.
Eight companies will be presented. All these Serie A deeptech companies are part of the European Invest Horizon 2020 acceleration program, and are looking for funds to continue their growth.
 
 
Here is the program :

3D Imaging Software for Bone Diagnosis
A medical imaging software development company in four key medical fields: arrhythmias, aneurysm, epilepsy and osteoporosis. They offer the medical technology industry fast and low-cost pathways for the creation of innovative and advanced solutions. They also provide an effective means of bringing these solutions to a growing global market. They achieve this by means of an in-house software development platform for the rapid prototyping of medical imaging applications.
Sales launch in 2018: 6 unites/ € 60K, pipeline > € 300K, CE Mark | € 1.8 M sought

 
Treatment of Localized Adiposity
The company has developed a technology that radically eliminates localized body fat excess (adiposity) and provides results never achieved until now: up to 5 cm. waistline reduction after one 20-minutes session. The company has developed a non-invasive medical device that also uses digital management of ultrasound, shape recognition based on based on IA, augmented reality guidance of the physician. This medical device is being CE marked and should reach the market this year.
The CE marking is in process (electrical tests validated, and technical file being audited). It will be followed by a short test phase in Paris before the beginning of the distribution | 5 M€ sought

 
Digital Health – Data Brooker
The company collects and processes pharmacies commercial data to build up a panel. It’s a data broker as SAAS provider for pharmacies, pharmacy chains, pharmaceutical labs. The data is accessed for their customers through APIs & self-service apps. They only collect commercial data, excluding any « personal » data. Data are extracted hourly from the pharmacy ERP and are only extracted through an explicit agreement and contract with the pharmacy owner. In these General Conditions, the pharmacy owner concedes the right to collect, process and commercialize the data.
They have already deployed the solution on 5,000 point of sales with a steady growth of the panel. | €2.5 M sought

 
Biotech – Neurodegenerative
A biopharmaceutical company dedicated to developing first in class molecules that address important medical needs in the field of neurodegenerative diseases and in the area of deafness.
All data generated from in vitro test methods enable to demonstrate the positive impact of the company on: Induction of neuronal differentiation of murine and human progenitor cells; Protection against toxicity-induced by glutamate and oxidative stress; Stimulation of connections between spiral neuronal ganglion cells and ciliated cells, which are responsible for hearing
Efficacity results from in vivo test methods support that they represent a new class of molecules effective for the purpose of treating patients with neuropathy/synaptopathy linked to hearing loss. | €8 M sought

 
Medical Device – Surgical Instrument for Gynecology
The company aims at serving the gynecology market with a new generation of pain-free single use surgical instrument, to replace the current middle-age painful cervical forceps affecting more than 75 million women every year in routine interventions requiring access to the uterine cavity. The company innovates women's care with new surgical instrument for gentler and more modern gynecological procedures.
12 reference letters from Medical Doctors | €3.5 M sought

 
Medical Device - Virtual Reality Solution
A company specialized in innovative medical devices. They offer healthcare facilities a therapeutic virtual reality solution aimed to alleviate the pain and anxiety of their hospitalized patients. Thanks to a virtual reality headset and a headphone, a patient is transported according to his preferences in rich and lively natural 3D environments like a forest or a mountain. Developed in collaboration with doctors, their virtual experiments are optimized for relaxation and pain distraction through advanced psychological principles such as hypnosis, music therapy or cardiac coherence induction.
They will reach > € 1M orders in 2019 | €2.5 M sought

 
Neurosurgical Platform - Glioblastoma
The company is developing a neurosurgical platform, built around a microrobot to deliver drugs in the brain for targeted therapies. The company as a first application is targeting glioblastoma, a deadly malignant and infiltrative brain cancer with limited survival time (12-16 months).
The technology is currently developed and tested inside hydrogel-based brain models and will be tested on preclinical tests starting in 2020 | €3.5 M sought

 
Biomarkers
The company seeks, develops and qualifies innovative biomarkers for the development of diagnostics in the field of neurological diseases. The purpose of the company is to translate new diagnosis methods for various neurodegenerative diseases into products, and to promote the use of these tests in clinical practice. Their know-how is based on the detection of blood biomarkers.
Currently their biomarker R&D program is dedicated to the clinical qualification of new biomarkers and diagnostic tools for the diagnosis and the follow-up of the Alzheimer’s disease | €2.5 M sought

 


Tuesday, June 11th 2019
The next Belgian e-pitch session will take place on Tuesday 18 June at 5 pm - Register here 

These sessions allow selected companies seeking capital to present their development / growth project. As usual, each manager will have a maximum of 8 minutes to convince you to follow him/her. You will be able to submit your questions online after each pitch.

Here is the selection : 
 
Cleantech - "Smart City through Smart Lighting"
Technology is based on deploying intercommunicating sensors along the streets to adapt, in real-time, street lighting levels to traffic density and type of users: "Light where and when needed". The energy savings are maximal and can reach up to 80%. The solution is also a good entry point for mobility management, a pillar of Smart Cities, opening the way to many applications by feeding information's, in a secure way, to traffic lights, pedestrian crossings, traffic and warning signs.  The infrastructure equipped with additional sensors can transport additional public space information like noise level, air quality, parking occupancy, ...
Partners: Cities and public operators. Deployment on more than 50 sites | Amount sought: €3.0m

 
Medtech
Company develops and markets evidence-based Digital Sedation technology to relieve pain and anxiety without medication in acute care patients.  It realizes these digital therapeutics by combining clinically-proven hypnosis with virtual reality into medical software. The company licenses its digital sedation software based on recurring revenue model, running in a device tuned for use in clinical setting. Over 10,000 patients treated plus 16 clinical studies (>1,600 patients) completed or ongoing, evidencing strong results. Current funding round aiming at international expansion and acceleration continuous R&D innovation.
10,000+ patients, 100+ healthcare centers, 0.4M€ invoiced - 2.8M€ raised to date | 10 M€ sought (staged) 

 
Smart Cities
Company developed an innovative e-commerce marketplace platform and administration mobile apps. The platform creates personalized websites / webshops for local shops and smart cities while the mobile apps allows our customers to manage their shops / events (for cities admin) or products / orders (for shops admin).
App adopted by +15 cities and +10,000 local shops | 2 M€ sought : international growth

 
Digital / Helping SMEs in their digital transformation
New generation digital and secure market network. The model is based on a revaluation of human resources services based on an essential element: the adoption of good practices. By overlaying and with the support of a major Belgian bank, the company recreates its "phygital" ecosystem around the self-employed, thus building the bridges essential to its development, for example: accountants, bankers, social secretariats, professional confederations. Creation of a unique and even monopolistic One-stop-shop at the Belgian level; this model only needs to be duplicated internationally. 
The partners: Belfius Bank, Partena, SD Workx. Several orders in progress. CES las Vegas 2019 | amount requested: : : 1 M€, already secured : 0,7 M€
 
Digital marketing 
The "TripAdvisor" of B2B professional service providers. Digital e-reputation platform to put the customer back in the spotlight. Enable companies to make better purchasing decisions and suppliers to win and retain customers.  Authentication of notifications via a LinkedIn profile to ensure the quality and objectivity of notifications.
Presence in 7 European countries in the next 12 months. Acceleration by the purchasing consulting firm Bridgewater. Project supported by Finance.Brussels | Amount sought: €0.6m

 
Media / MusicTech
Mobile platform that removes barriers between artists and their fans. It allows everyone - regardless of age or musical level - to produce high quality remixes in minutes. Catalogue of 40+ international artists including Roméo Elvis (Be), Le Motel (Be), 20Syl (Hocus Pocus, Fr), Klever (Yelawolf, US), ...
Played by A$AP Rocky in his 2019 tour (US/Asia/US). Used in Adidas' marketing campaigns. More than 1m of downloads worldwide. | Amount requested: €0.8m
 

You wish to attend? You can register now via this link.

​If you have any question, please contact Christine Margrève (cmargreve@sowalfin.be )


Tuesday, June 11th 2019
ESIL Webinars: All events in June
Find the next Webinars offered to investors and Business Angels:
  • Manage investments and follow-on rounds - Wednesday 5th of June at 13:00 CEST
  • Exit Investments - Monday 17th of June at 13:00 CEST
 
Manage investments and follow-on rounds - Wednesday 5th of June at 13:00 CEST

Why should you join this webinar?
Business Angels can take an important role to help the companies they invest in; learn why this is important and some examples. During the investment cycle entrepreneurs will face different challenges and investors can provide some support. Understand what Follow-on rounds are, when you can expect them to happen and the different types. Why do entrepreneurs and investors need these documents? Understand the differences and similaries among Term Sheet, Shareholder Agreement and Statutes. Learn the key components these documents should cover, main clauses and how to create and negotiate them.

What will be covered?
  • How and Why do Angels contribute know-how/support in addition to financing?
  • What are common challenges entrepreneurs face that angels should recognize?
  • When do follow-on rounds usually occur and how do they work?
 
Register: http://events.gobeyondinvesting.com/esil_web_190605
 

ESIL Webinars: All events in June
Exit Investments - Monday 17th of June at 13:00 CEST

Why should you join this webinar?
Finally, the Exit is here! What and when are the investors receiving? Do not forget the tax considerations! Learn what type of Exits might be and what triggers the most common ones. During the Investment Cycle, Exit will be a main topic of discussion, how should you face each stage to increase the chances of success?

What will be covered?
  • How do investors Exit investments?
  • What are the more common types of Exits for Business Angels?
  • Sale of the start-up to a larger company
  • Bankruptcy
  • Repurchase of shares by new investor or founders/startup
  • How does the subject of Exit come up during the life of a startup?
 
Register for this webinar here


Tuesday, June 4th 2019

InvestHorizon is a programme financed by the European Commission in association with Eureka to foster investment readiness. The InvestHorizon Accelerator is for selected deep tech companies to facilitate series A funding.

EuroQuity will be there on the 7th, in charge of the first pitch session of the Accelerator programme. 


InvestHorizon kick-off - Discover the second list of top deeptech companies selected in the health sector | Paris, June 7th
The pitching event at a glance:
  • 07th of June from 09:00 to 12:00 CET at Bpifrance's offices 6/8 boulevard Haussmann. 
  • +20 serie A european companies pitching. Two Parallel sessions. 7 min pitch / 5 min Q/A
This invitation is limited to our investment partners (register). Don’t miss out on this great opportunity and save your spot now! 

Here is the first list of deeptech companies:

​___________________________________

Biotech – Transthyretin amyloidosis
A biotech company focused on the design of organ-targeted, high-quality drug candidates for the treatment of life-threatening transthyretin-mediated amyloidosis (ATTR). They work closely with patients and physicians to understand and answer to multiple clinical manifestations of these pathologies which represent unmet medical needs.
The company has succeeded in designing novel and potent TTR stabilizes endowed with physicochemical and pharmacological requirements for the development of two innovative products | €2.5 M sought
 

Digital Health
The company is developing an innovative e-health solution, a web and mobile platform, certified as a medical device, to improve the care of patients whose state of health requires long-term care (chronic, complex).
It allows healthcare professionals, patients and their families to co-define a personalized care plan that is monitored in real time through integrated instant collaboration mechanisms (chat, video). It aims to empower the patient.
They have contracts in France and a strong position in the Canton of Geneva in Switzerland. A pilot is being organized with the Moroccan Ministry of Health | €2.5 M sought
 
 
Biomarkers
The company seeks, develops and qualifies innovative biomarkers for the development of diagnostics in the field of neurological diseases. The purpose of the company is to translate new diagnosis methods for various neurodegenerative diseases into products, and to promote the use of these tests in clinical practice. Their know-how is based on the detection of blood biomarkers.
Currently their biomarker R&D program is dedicated to the clinical qualification of new biomarkers and diagnostic tools for the diagnosis and the follow-up of the Alzheimer’s disease | €2.5 M sought
 

Healthtech – Heart Diseases
The company aims to develop biomedical technology (software and devices) for children with heart diseases. Product line includes patented powerless pediatric asset devices and heart valves already tested in patients. The company also provides blood flow design platforms for cardiovascular surgeons tested in patients. These interactive tools allow surgeons to predict the outcome of their intended operations prior to the actual surgery.
50 surgeons had interest | €500 K sought
 

Arthroscopic Method
In order to solve the problem of superficial cartilage wounds, the company has developed a patented method, that consists to apply a liquid dye that fixes at the surface of the cartilage. It absorbs the light from the laser, enabling to use much less power: even in the absence of the dye, the laser light diffuses without any danger through the articular cartilage. The surgeon will resurface the articular cartilage with the arthroscopic laser. He will withdraw a thin layer of damaged cartilage, leaving a smooth surface. The articulation can then start to function properly.
Instruments and consumables ready for marketing and sales (veterinary market) | €3 M sought
 

Robotic Assisted Rehabilitation
The company is developing and supplying solutions to the emerging market of robotic assisted rehabilitation (RAR) services, using the most advanced technology in their robotic devices, integrating electronics, mechatronics, informatics and telecommunication technologies. They develop a wearable robotic device for knee rehabilitation. It incorporates “assisted as needed” control and functional electrical stimulation (FES) features, helping to speed-up and to improve the rehabilitation process. 
Preliminary contacts to check market acceptance have been carried out with posi6ve results| €1.5 M sought 
  

Medical Device - Neurodegenerative disease
A company that has developed a device, a proprietary medical device to treat motor symptoms of neurological and neurodegenerative conditions. It is effective in treating invalidating mobility problems caused by stroke or Parkinson’s disease. These symptoms do not have adequate response to currently available treatments. Device efficacy has been documented via clinical trials and peer-reviewed publications. Already CE mark and has been accepted by the US FDA in the “Breakthrough Devices Program”, a fast track procedure to expedite patients’ access to innovative medical devices that address unmet medical needs.
400 devices sold mainly in Italy+CH ; CE marked and FDA marketing authorization is expected in mid-2020 | €2.5 M sought
 

Medical Device – Surgical Instrument for Gynecology
The company aims at serving the gynecology market with a new generation of pain-free single use surgical instrument, to replace the current middle-age painful cervical forceps affecting more than 75 million women every year in routine interventions requiring access to the uterine cavity. The company innovates women's care with new surgical instrument for gentler and more modern gynecological procedures.
12 reference letters from Medical Doctors | €3.5 M sought
 

Medical Device - Virtual Reality Solution
A company specialized in innovative medical devices. They offer healthcare facilities a therapeutic virtual reality solution aimed to alleviate the pain and anxiety of their hospitalized patients. Thanks to a virtual reality headset and a headphone, a patient is transported according to his preferences in rich and lively natural 3D environments like a forest or a mountain. Developed in collaboration with doctors, their virtual experiments are optimized for relaxation and pain distraction through advanced psychological principles such as hypnosis, music therapy or cardiac coherence induction.
They will reach > € 1M orders in 2019 | €2.5 M sought


Paradigm of respiratory care
The product of the company is shifting the paradigm of respiratory care in chronic patients. Their proprietary CE-marked device is a mobile ultra-portable spirometer, connected with a smartphone via dedicated apps for patients and physicians. Providing highest, hospital-grade accuracy it has been recognized by leading experts in the field as groundbreaking technology. It allows for full a spirometry examination performed by patient at home as well as in doctors’ office.
CE-marked device | €8 M sought
 
 
Neurosurgical Platform - Glioblastoma
The company is developing a neurosurgical platform, built around a microrobot to deliver drugs in the brain for targeted therapies. The company as a first application is targeting glioblastoma, a deadly malignant and infiltrative brain cancer with limited survival time (12-16 months).
The technology is currently developed and tested inside hydrogel-based brain models and will be tested on preclinical tests starting in 2020 | €3.5 M sought
 

Biomechanics
The company is active ly involved in the fields of physical rehabilitation and sports biomechanics producing precise measuring and training devices for assessment/exercising and follow-up of patients and athletes.
The product is the first centralized solution for functional evaluation and monitoring. It consists of an application and 5 devices to cover almost all the functional work in rehabilitation.
 €360 K turnover; +700 Users | €1.3 M sought
 

Bio-wearables Health
An advanced bio-wearable company currently working on its innovative technology. This technology will allow the analyze of key physiological markers by simply “tasting” the skin rather than analyzing blood samples.
It will enable a precise and continuous monitoring of systemic glucose level anytime and anywhere.
Excellent results in 1st preclinical animal study, > 99% accuracyPreclinical; CE mark expected mid 2022 | €10 M sought
 
 
Healthtech – Holographic 3D solution
A hard-tech company specializing in disruptive holographic 3D solutions from motion video displays to static images. Their technology does not need any head gear where 3D images appear in mid-air, viewable naturally. They have an experienced team delivering on extreme hardware, software and 3D graphics projects. They offer a 3D light-field display capable of showing color motion video, as well as static digital holograms. They can convert any kind of 3D digital data into a hologram. The main applications are in medical imaging, scientific data visualization and engineering design.
Already 43 Medical Professional customers | €2.5 M sought
 

Nanobiotechnology - Cancer Diagnostics
The company has developed a proprietary nanoparticles deposition technology that allows to functionalize any surface providing some unique features in cell biology.
Clinical proof of concept in progress | €5 M sought

 
Physiological diagnostics and therapy
The company has participated in several medical instrument development projects and implemented cardiovascular and pulmonological technologies.
The innovation offers integrated solutions in any of the domains of CVD prevention and early diagnostics, remote care and rehabilitation for many people.
Number of customers approx. 60.000 in Year5 | €2.5 M sought
 


Wednesday, May 29th 2019
Apply to the European Data Incubator open call 2019
Are you ready to grow your big data startup? Are you a bright European SMEs or start up working on big data challenges? Then apply for the European Data Incubator open call 2019.

What is the European Data Incubator?
EDI is an exciting incubation programme for Big Data startups and SMEs in Europe.

What's in it for you?
  • Up to €100K free funding
  • Free support services and workshops by dedicated mentors
  • A free Cloud environment for scalable data processing
  • Direct access to major European corporates from different sectors
  • The chance to solve a real-life data challenge
 
How does it work?
EDI is a three-phase incubation programme: Explore, Experiment, Evolve.

 


Apply to the European Data Incubator open call 2019
Am I eligible?
  • Location:​ SME/start-up legally established in one of the eligible countries described below.
  • SMEs must comply with the Commission Recommendation 2003/361/EC  and the SME user guide.They must fulfill these criteria:
  • Headcount in Annual Work Unit (AWU) less than 250.
  • Annual turnover less or equal to €50 million or annual balance sheet total, less or equal to €43 million.
Only one proposal per SME is allowed.
  • Group of individuals​: When there is not a constituted SME, the applicants could be a group between 2 to 4 individuals legally established in one of the eligible countries as describe below. A written commitment to have set up a legally registered SME if reaching the second phase of the incubation (the “Experiment” phase) will be required.
Only applicants legally established, and working, in the case of the individuals, in any of the following countries will be eligible:
Applications are open until Wednesday 19 June at 12:00 pm CEST, apply now on F6S.
For more information, please contact Julien Toussaint


Tuesday, May 28th 2019
Register to the next ESIL e-pitch session featuring French startups, on May 28th at 3:00 PM CEST
Our next ESIL pitch session will be held online tomorrow, from 3 to 4 PM CEST.
Five companies will be presented. They were all seed- funded  by the largest French business angels networks, and are now ready for the next round.
 
Register here! - Do not hesitate to share to syndicate with your colleagues.
  • The following sectors will be represented : medtech, audio/video, smart city, music, art…from 0.95 k€  to 2M€ tickets.
  • Companies are also looking for commercial partners. That would be appreciated if you could help them with connections. Other angels will do the same for you next time!
  • Even if you do not invest, we recommend you to come and get an overview of the current technologies.
 
You are most welcome. Here is the program :
__________________
Medtech / Remote Health Monitoring
We have developed the first wearable thermometer for continuous & remote patient monitoring. This medical device is sold in pharmacies in various countries (B2C market) and has received high customer satisfaction. Now enlarging to B2B market (OEM business model) and Hospitals (efficient mean to reduce cost of care).
Penetration of various EU countries (leader), Major OEM contract with 1st rank laboratory, Selected by 3 hospitals (UK, FR), Medical certification (ISO13485), European Patent 1.5 M€ sought

Audio / Video 
Augmented Reality capable mobile device that people will actually want to wear: The world's first AR headphone. This new device is a "visual headphone" seamlessly blending audio with an AR display to create a brand-new user experience and its own product category.  It is a disruption to existing paradigms and will enable mobile video music steaming and new AR applications.
32 Granted Patents, 420K in revenue last year, Seal of Excellence Award for H2020 SME Instrument PH2, IDC Innovator of the Year | 2 M€ sought 

Industrial Predictive Maintenance
Our platform collects traffic data to optimize the operations of industrial sites and urban logistics, allowing a systematic and complete characterization of vehicles. We create a brick to the smart city, for less polluting and safer mobility, starting with pragmatic use cases of our industrial and institutional customers.
Poc successfully completed, several orders in progress | 2 M€ sought

Social Platform / Music

88 million musicians around the world are looking for their favorite songs to play on their instrument. Over 50% of them won’t find the right resources to do so. The company connects professional musicians and amateurs around sheet music, video tutorials and music lessons. Learners will be able to ask for tips, show off their progress and find the next song to add to their repertoire. With such a social, fun and competitive environment, learners will never let their instruments gather dust again!
+800K monthly visits on the platform  | 0.95 M€ sought

VR / Art
We have developed the first museum in virtual reality which contributes to the digital democratization of culture: making art accessible, familiarizing people with the museum, valorising the collections, and taking part in artistic entertainment by conceiving immersive exhibitions in virtual reality.
Already 150k active users | 1.3 M€ sought
_____________
 
Register here


Monday, May 27th 2019

InvestHorizon is a programme financed by the European Commission in association with Eureka to foster investment readiness. The InvestHorizon Accelerator is for selected deep tech companies to facilitate series A funding.

​EuroQuity will be there on the 7th, in charge of the first pitch session of the Accelerator programme. 


InvestHorizon kick-off - Discover our first list of top deeptech companies selected in the health sector | Paris, June 7th
The pitching event at a glance:
  • 07th of June from 09:00 to 12:00 CET at Bpifrance's offices 6/8 boulevard Haussmann. 
  • +20 serie A european companies pitching. Two Parallel sessions. 7 min pitch / 5 min Q/A
This invitation is limited to our investment partners (register). Don’t miss out on this great opportunity and save your spot now! 

Here is the first list of deeptech companies:

​___________________________________
 

Biotech – Diagnostic Tests
A biotech corporation created to bring revolutionary technologies to the market of personalized molecular diagnostics. Their mission is to eliminate cancer misdiagnosis by creating reliable, 100% accurate, quantitative and affordable diagnostic tests. The company is launching its next generation of revolutionary diagnostic tests, which can precisely identify and quantify cancer markers.
Has generated €200k in revenues since 2016 by selling sub-products | €2.5 M sought


Biotech – Neurodegenerative
A biopharmaceutical company dedicated to developing first in class molecules that address important medical needs in the field of neurodegenerative diseases and in the area of deafness. All data generated from in vitro test methods enable to demonstrate the positive impact of the company on: Induction of neuronal differentiation of murine and human progenitor cells; Protection against toxicity-induced by glutamate and oxidative stress; Stimulation of connections between spiral neuronal ganglion cells and ciliated cells, which are responsible for hearing
Efficacity results from in vivo test methods support that they represent a new class of molecules effective for the purpose of treating patients with neuropathy/synaptopathy linked to hearing loss | €8 M sought
 

Biotech – Phenylketonuria
A biotech company aiming to develop novel therapies to treat diseases caused by protein misfolding. Their first disease target is phenylketonuria (PKU), a rare genetic disease of metabolism. The development program is based on the company's intellectual property on the screening and development of small molecule pharmacological chaperones with the potential to stabilize/maintain the native structure of the protein involved in the disease.
Promising proof of principle in vitro and in vivo, with line of sight to a de-risked preclinical candidate | €2.5 M sought
 

Digital Health – Generate Personalized Diagnosis and Prognosis reports
All-in-One Platform for Storage, Management and Usage of Genetic Data within Clinical Practice. It fills the gap between patients, physicians, geneticists and genetic labs, creating a symbiotic network to make genomic based medicine truly part of everyday medical practice. Individuals willing to sequence their DNA, can proactively do so once, and only once. Their Genomic data is stored for lifetime in their system and, whenever needed, the individual gives access to his/her physician - any specialist, non-geneticist, to query the genomic data for the relevant for the practice. Genetic reports are then automatically generated, using a user-friendly language, with actionable information, presented in an uncomplicated form.
First sell in 2016 | €10 M sought €3.6 M have been secured


Digital Assistant for Long-Term Care
The company has developed a technology for Contact-Free Continuous Monitoring (CFCM) of activity parameters for nursing homes, to reduce the incidence of falls and bedsores. It is a novel software-only technology leveraging deep learning and computer vision analytics which, coupled with off-the-shelf cameras (CCTV), provides insights and multiple smart alerts, reposition reminders and reports for caregivers.
Secured key partnerships with hardware providers, distributors, Electronic Health Records (EHR) providers | €800 K sought €400 K have been secured

 
Digital Health – Data Brooker
The company collects and processes pharmacies commercial data to build up a panel. It’s a data broker as SAAS provider for pharmacies, pharmacy chains, pharmaceutical labs. The data is accessed for their customers through APIs & self-service apps. They only collect commercial data, excluding any « personal » data. Data are extracted hourly from the pharmacy ERP and are only extracted through an explicit agreement and contract with the pharmacy owner. In these General Conditions, the pharmacy owner concedes the right to collect, process and commercialize the data.
They have already deployed the solution on 5,000 point of sales with a steady growth of the panel | €2.5 M sought
 
 
Diagnostics for Sleeping Disorders

A company with extensive experience in audio analyzing technology for sleeping disorders. The company collaborates with leading medical technology industries and hospitals worldwide. Their mission is to improve the quality of life for those who suffer from sleeping disorders by providing them with healthy, secure, reliable and robust solutions.
The company has proceeded fast with development and the product launch takes place in Q3/2019 | €4.2 M sought

 
Thermotherapy for Treatment of Cancer

The company offers a new approach to thermotherapy for treatment of cancer. It increases efficacy of radio- or chemotherapy up to 50%. Thermotherapy has no negative side effects for patients. They use microwave antennas with precision control through software to heat the tumor. Nearby sensitive organs are fenced off from the heat. Therefore, it can be used on many tumor types, even deep within the body. The patented technology is unmatched in industry.
Patented proven clinical prototype; 70 patients treated; Community of 10 clinics | €6 M sought - Tranche 1: €3.2 M - Tranche 2: €2.8 M
 
 
3D Imaging Software for Bone Diagnosis
A medical imaging software development company in four key medical fields: arrhythmias, aneurysm, epilepsy and osteoporosis. They offer the medical technology industry fast and low-cost pathways for the creation of innovative and advanced solutions. They also provide an effective means of bringing these solutions to a growing global market. They achieve this by means of an in-house software development platform for the rapid prototyping of medical imaging applications.
Sales launch in 2018: 6 unites/ € 60K, pipeline > € 300K, CE Mark | € 1.8 M sought
 
 
Treatment of Localized Adiposity
The company has developed a technology that radically eliminates localized body fat excess (adiposity) and provides results never achieved until now: up to 5 cm. waistline reduction after one 20-minutes session. The company has developed a non-invasive medical device that also uses digital management of ultrasound, shape recognition based on based on IA, augmented reality guidance of the physician. This medical device is being CE marked and should reach the market this year.
The CE marking is in process (electrical tests validated, and technical file being audited). It will be followed by a short test phase in Paris before the beginning of the distribution | 5 M€ sought


_______________________________
 
InvestHorizon kick-off - Discover our first list of top deeptech companies selected in the health sector | Paris, June 7th


Friday, May 24th 2019

For the Romanian Presidency of the EU, the European Commission organizes in Bucharest from June 19th to 22nd the key event on innovation funding.

EuroQuity will be there on the 20th, in charge of a pitch session featuring the best European companies that were awarded with the Seal of Excellence label.


The most promising European companies raising capital - from 0.3 to 20 M€ | Bucharest June 20th
The Innovative Enterprise Conference will take place in Bucharest at the Polytechnic University of Bucharest (UPB) Campus.
EuroQuity organizes a pitch session with 20 of the best potentials awarded with the Seal of Excellence, on June 20th at 2 pm. 
All our partners and colleagues investors are cordially invited, including to watch the live webcast  (registration here ).

Here is the Seal of Excellence program:
______________________________

IT - IoT - Robotics - Cybersecurity - Fintech


Cybersecurity / Deception Technology
We succeed where cybersecurity prevention struggles. We operate from behind the firewall and acts as an additional layer of protection and extension of the existing security systems.
Partner with 20 top resellers in Europe and 10 in RoW - Awarded to MOST PROMISING COMPANY by global cybersecurity jury - Winner of the BORN GLOBAL CHAMPION - Winner of the Go Silicon Valley program 3M€ sought – Austria

IT / Blockchain
We are digitizing the $4.5Trillion commodity trading, commodity finance and commodity supply chain market, making it more efficient, green, sustainable and faster by deploying emerging technology such as Cloud, AI, IoT and DLT. We are a product ready and revenue generating company growing 100% YOY since 2017. Winner of several innovation awards | 3M€ sought – UK

Fintech

One stop shopping finance platform for SME. Invoicing - dunning - instant payments -fx-hedging - lending - factoring - investments - and more. Everything for the management of working capital at one place. Fully integrated, simple & fast.
Partner with people’s bank in Germany, Seal of Excellence Holder of Horizon 2020 Project from European Union, Cooperation with Frankfurt School of Finance & Management Blockchain Center, Cooperation agreement signed with one of Germany’s biggest e-invoicing companies, 10+ Customer LOIs signed | 2M€ sought - Germany

IT Infrastructure / Cloud management

True Private Cloud platform that manages your resources intelligently across cloud providers, private servers and individual nodes, all behind a single API & UI. We consolidate local data centers into a coherent international network to provide automatic compute resource brokerage. Platform deployed on top of 2 data centers in Estonia and currently on-boarding next ones in Jakarta. Secured ca 1MEUR including Enterprise Estonia grant (355 K€)1.5M€ sought – Estonia

IoT / Consumer Products / Ed-Tech
Children can code robots before the even read. We developed and patented tangible coding language that is LEGO compatible, and transforms the world of coding into a playful experience. Production line recently established.
Signed 5M€ distribution agreements, received 1M€ in orders, signed 2M€ distribution LOIs, distribution in 50 countries via 170 franchisees | 1.5M€ sought – Israel

Cybersecurity / Identity and Access Management

We strive to create easy-to-use, comprehensive digital authentication solutions that support reliable and convenient endpoint identity and access management. Our flagship product is a multi-purpose wireless security key. It has encrypted storage with consolidating different authentication tools - password storage, One-Time-Password generator, Fido token, Blockchain signature for PCs, smartphones, and tablets, and also RFID/NFC key for physical access.
Sold 5k units - Alumni Mach37 Cyber Security Accelerator - Integrated and partnership with two global access management platform - Winner of the Vernadsky Challenge Award - Winner of the UVCA Challenge. |1.5M€ sought – Ukraine

Robotics / Machine Vision / Smart Manufacturing
We develop a vision guidance system for robotic arms making robots smarter with a unique adaptive vision control. The device will improve robot’s precision and reactivity, taking on new manufacturing challenges and guaranteeing a genuine collaboration between humans and robots.
Partner with First Collaborative Robot Manufacturer Universal Robots (Italy) – Jury Award at the NTT Data Open Innovation Contest 9.0 – 2nd Ranked at the Best Practices Innovation Contest Confindustria | 350K€ sought – Italy

IT / Automotive / Smart Building / Smart Cities / AI
We're making an infinitely scalable / module multi-sensor AI camera system for the next generation of computer vision-centric cameras running AI on the edge. 1st product is a 12K camera for mapping.
Already 1.5 years in development based on 8 previous years of experience in camera design; 1st version of hardware finished, revenue from customers today, loved by Google & BBC1.5M€ sought – Czech
______________________________
 

Cleantech


Plastic Recycling / Circular Economy
A unique technology able to de-ink surface-printed film and therefore can deliver high quality post-consumer recycled plastic avoiding the actual down-cycling.
Finalist of the Plastics Recycling Awards Europe 2019 in “Product Technology Innovation of the Year”- Winner of the “Flex Pack Recovery Challenge” from the Sustainable Packaging Coalition | 2M€ sought - Spain

Machinery / Energy / IoT
We democratize levitation technology and make it available for any industry. We provide high-speed electrical machine design and serial production of active magnetic bearings for original equipment manufacturers. Our solution lowers lifecycle costs by 35%.
First paying customers attracted – NDAs and LOIs with European OEMs of compressors, blowers and generators – Part of the consortium developing cooling system for the DEMOnstration unit – Member of Cleantech Finland and Solar Impulse Foundation – Finalist at Slush and Arctic 15 – Accelerated by European Institute for Innovation and Technology Climate-KIC, Accelerace and EnergySpin | 1.5M€ sought – Finland

Energy-Efficiency / Flexibility / Storage

An award-winning Norwegian Technology company that has developed a novel Thermal Battery technology to help customers across the entire energy system maximize the value of their energy. We help reducing the greenhouse gas emissions by cutting use of fossil fuels and support the increased share of renewable energy by flexibilization of power plants and enabling 24/7 solar energy.
Winner Nordic Cleantech Open 2017, WWF climate solver award 2017, SME-1 p.2 grant in 2019 | €20m sought – Norway

Renewable Energy /
Plastic Recycling
We are tackling two of Europe’s biggest issues: air pollution and eradicate unrecyclable plastics, worn tires and toxic waste for a good profit. Vision: Produce a zero-emission transport fuel (H2) and stop sending waste to landfill and turn waste into revenue.
Received Horizon 2020 “Seal of Excellence «certificate, NDV-GL verification NDAs and LOIs signed by leading industry companies (ENGIE, ENEGAS, TOYOTA OSHUA)9 M€ sought – Romania/UK

Water purification
We developed a ground-breaking plasma-based solution for the complete purification of waste water from Persistent Organic Pollutants (POPs).
Partner with Scottish water - Winner PwC Local to Global Award - Seed4Start selection - First Prize World Green Design Forum Yangszhou - Eureka Label - Second Prize Changchun Overseas Talents Competition - Seal of Excellence - First clients signed up in UK, China | 3M€ sought - Belgium/Luxembourg

Renewable Energy / wind energy
We develop a new system aimed to gather faster and more powerful altitude wind energy, providing affordable renewable energy on a wider scale. Our technology can trigger energy transition to renewables, without the need of public incentives, particularly windy sites and large dedicated areas.
Winner of IMD prize, De Vigier Prize, Imagine IF Prize, European Space Agency BIC-CH incubatee, winner of Venture Kick CH and supported by the Swiss Federal Office of Energy | 3M€ sought – Switzerland

Renewable Energy / Storage / Industrial Process Heat

The first worldwide concept about a Photovoltaic (PV) Plant with thermal cogeneration, based on a hybridization of standard PV plant with a Concentrated Solar Power (CSP) Tower by means of patented optical light selective filters. Cost of storage 10 x more effective than current batteries and 2x more economical than CSP technologies. Production of heat 2x cheaper than average price of Natural Gas.
Project awarded by Spanish Centro de Desarrollo Tecnológico Industrial under INNTERCONECTA 2016 and 2018 calls. 2M€ raised previously. Partnership with the major Technological Centre in Spain. Selected by the most important CSP Developer worldwide as technological partner for this new solar plant concept2-5 M€ sought – Spain
______________________________
 

Medtech - Agtech


Biotech / Organ-on-chips
We propose an innovative solution for screening drug toxicity and efficacy, with the final aim to improve drug discovery pipeline (DDP) and lead to a more efficient, faster and less expensive launch of drugs into market. Our solution is based on human beating organ-on-chips platforms that create preclinical models featuring an unprecedented and realistic resemblance to human native organs (i.e. heart) and disease (i.e. joint degenerative pathologies).  
Winner of the Termis Business Plan Competition 2018 – Finalist of the 2018 EIT Headstart competition - Winner of the 2018 Switch to Product Competition promoted by Politecnico di Milano – Winner of StartCup Lombardia 2017 – Finalist of 2016 Bioupper competition promoted by Novartis and Fondazione Cariplo | 0.7M€ sought– Italy

Medtech / Cardiovascular
Novel navigation system to guide cardiovascular interventions, high-end pacemaker treatments and ablation procedures in particular. Currently, 30% of patients have no benefit.
Clinical proof-of-principle achieved, CE mark obtained and product to be launched in Q3, 2019. Initial partnership with one of the big 4 companies in the pacemaker market established |1M€ sought - Netherlands

BioTech / Healthcare
We develop a unique bioactive coating that solve three main challenges for dental implants; better stability, avoiding infections and better aesthetics. This groundbreaking technology will open new markets by enable implants in difficult patient groups and the dental product serve as a proof of concept before entering the 10 times larger orthopaedic market.
Seal of Excellence May 2019 in Horizon 2020 – Vinnova MedTech4Health 2018 – Vinnova “Runner up SME instrument 2017”–Winner of the SKAPA “Best innovation” 2010 | 1.6M€ sought – Sweden

Biotech / Agtech

Using pharma production technologies, we are bringing quality at costs to crop-yield enhancing bioactives. Our first product Arbuscular Endomycorrhizal Fungi (AMF), conveys yield increases and water saving effects to plants. Our proprietary bioreactor design allows, for the first time, cost efficient production of AMF to help farmers world-wide to grow more with less.
Science 2 Business Award 2017, Mercur Award 2017, 2018 Top 500 DeepTech StartUps World Wide, 2019 Finalist Industrial Biotech Startups Europe, Pre-existing investors from seed industry (BayWa, RWA, Mauthner) | 2.5M€ sought – Austria
______________________________
 
Please fill up this form to register to the live webcast!


Friday, May 17th 2019
Register to the first InvestHorizon Webinar on Series A raise on May, the 14th at 4pm
The webinar’s topic is eHealth. To shed some light on this subject, Roger Franklin, partner at Hadean Ventures, and Vincent Keunen, Founder & CEO of Andaman7, will share their insights with the audience.
 
What the webinar is about?
 
  • The prerequisites to raising a Series A
  • How to manage relationships with existing investors
  • Effective fundraising materials
  • Finding the right fit for my scale-up company
  • How to approach and convince venture capitalists: avoiding common pitfalls when approaching investors
 

​Register to the webinar by clicking here


Who is this webinar for?
 
If you have been successful at raising an early stage investment round and you are wondering how to achieve the next stage, if you have questions about how to successfully prepare for and raise a Series A and if you want to receive real and inspiring information from professionals in the eHealth sector, as well as have the opportunity to ask your own questions then you should join this webinar!
 
Duration: 45 minutes
 
If you want to know more about our speakers:
 
  1. Roger Franklin is Partner at Hadean Ventures, Nordic venture capital firm based in Oslo and investing in healthcare companies. Roger’s presentation will highlight the prerequisites to raise a series A investment, how to pick the right venture capital firm, convince it to step in and ways to handle the relationship with existing investors. (10 min with 10 min Q&A)
     
  2. Vincent Keunen, Founder & CEO of Andaman7, a Belgian-American eHealth company based in Liege. Vincent will share his investment journey through series A: pitfalls, practical advice, benefits, what to avoid, difference with his seed stage investment (10 min with 10 min Q&A)
  The webinar will be moderated by Javier Echarri, CEO of EBN – European Business & Innovation Centres Network
Register to the first InvestHorizon Webinar on Series A raise on May, the 14th at 4pm


Thursday, May 9th 2019
1 2 3 4 5 » ... 8
 
Stay informed by suscribing to our newsletter